Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine versus magnesium sulfate for prevention of postoperative shivering after cesarean section
IRCT20160825029520N2Phase 3Completed
- Sponsor
- Neyshabour University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in postanesthetic shivering (PAS) comparing Dexmedetomidine + bupivacaine, Magnesium sulfate + bupivacaine and Control: bupivacaine + normal saline (3 arms). Primary endpoints: Shivering and Physiological parameters. Started Dec 2018; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfatebupivacaine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20160825029520N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160825029520N2.